Details for Patent: RE45573
✉ Email this page to a colleague
Which drugs does patent RE45573 protect, and when does it expire?
Patent RE45573 protects LATUDA and is included in one NDA.
Protection for LATUDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fourteen patent family members in eleven countries.
Summary for Patent: RE45573
| Title: | Process for producing imide compound |
| Abstract: | The present invention provides an excellent industrial process for producing an imide compound hydrochloride. The process for producing an imide compound hydrochloride of the formula (2): ##STR00001## or an enantiomer thereof, which comprises treating a compound of the formula (1): ##STR00002## or an enantiomer thereof with an aqueous hydrochloric acid solution in a hydrophilic solvent, followed by crystallizing the resultant. |
| Inventor(s): | Kakiya; Yuzo (Ibaraki, JP), Oda; Mayumi (Osaka, JP) |
| Assignee: | Sumitomo Dainippon Pharma Co., Ltd. (Osaka, JP) |
| Application Number: | 14/137,464 |
|
Patent Claim Types: see list of patent claims | Use; Compound; Process; |
Drugs Protected by US Patent RE45573
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-003 | Dec 7, 2011 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-001 | Oct 28, 2010 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-005 | Jul 12, 2013 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-002 | Oct 28, 2010 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE45573
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2003-281860 | Jul 29, 2003 |
| PCT Information | |||
| PCT Filed | July 27, 2004 | PCT Application Number: | PCT/JP2004/011035 |
| PCT Publication Date: | February 03, 2005 | PCT Publication Number: | WO2005/009999 |
International Family Members for US Patent RE45573
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 543817 | ⤷ Sign Up | |||
| Australia | 2004259305 | ⤷ Sign Up | |||
| Brazil | PI0413081 | ⤷ Sign Up | |||
| Canada | 2538265 | ⤷ Sign Up | |||
| China | 100422178 | ⤷ Sign Up | |||
| China | 1832946 | ⤷ Sign Up | |||
| Denmark | 1652848 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
